These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4083391)

  • 1. Lipid composition of the cerebral gray and white matter in a case with Fukuyama type congenital muscular dystrophy.
    Eda I; Takashima S; Ohno K; Takeshita K
    Brain Dev; 1985; 7(5):523-5. PubMed ID: 4083391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormality of cerebral gangliosides in Fukuyama type congenital muscular dystrophy.
    Izumi T; Hara K; Ogawa T; Osawa M; Saito K; Novo ML; Fukuyama Y; Takashima S
    Brain Dev; 1995; 17(1):33-7. PubMed ID: 7762760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional MR imaging of brain surface anomalies in Fukuyama-type congenital muscular dystrophy.
    Toda T; Watanabe T; Matsumura K; Sunada Y; Yamada H; Nakano I; Mannen T; Kanazawa I; Shimizu T
    Muscle Nerve; 1995 May; 18(5):508-17. PubMed ID: 7739638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered alpha1-syntrophin expression in myofibers with Duchenne and Fukuyama muscular dystrophies.
    Wakayama Y; Inoue M; Kojima H; Jimi T; Yamashita S; Kumagai T; Shibuya S; Hara H; Oniki H
    Histol Histopathol; 2006 Jan; 21(1):23-34. PubMed ID: 16267784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipids of myelin, white matter and gray matter in a case of generalized deficiency of cytochrome b5 reductase in congenital methemoglobinemia with mental retardation.
    Hirono H
    Lipids; 1980 Apr; 15(4):272-5. PubMed ID: 7374382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical analysis of dystrophin in congenital muscular dystrophy.
    Arikawa E; Ishihara T; Nonaka I; Sugita H; Arahata K
    J Neurol Sci; 1991 Sep; 105(1):79-87. PubMed ID: 1795174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breached cerebral glia limitans-basal lamina complex in Fukuyama-type congenital muscular dystrophy.
    Saito Y; Murayama S; Kawai M; Nakano I
    Acta Neuropathol; 1999 Oct; 98(4):330-6. PubMed ID: 10502035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital muscular dystrophy with characteristic radiological findings similar to those with Fukuyama congenital muscular dystrophy.
    Garg A; Gulati S; Gupta V; Kalra V
    Neurol India; 2004 Dec; 52(4):496-8. PubMed ID: 15626844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress in the brain of Fukuyama type congenital muscular dystrophy: immunohistochemical study on astrocytes.
    Yamamoto T; Shibata N; Kobayashi M; Saito K; Osawa M
    J Child Neurol; 2002 Nov; 17(11):793-9. PubMed ID: 12585716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular alterations in Fukuyama type congenital muscular dystrophy.
    Sugino S; Miyatake M; Ohtani Y; Yoshioka K; Miike T; Uchino M
    Brain Dev; 1991; 13(2):77-81. PubMed ID: 1892223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal expression of dystrophin-associated proteins in Fukuyama-type congenital muscular dystrophy.
    Matsumura K; Nonaka I; Campbell KP
    Lancet; 1993 Feb; 341(8844):521-2. PubMed ID: 8094772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical studies in Huntington's chorea. VII. The lipid composition of the cerebral white and gray matter.
    Hooghwinkel GJ; Bruyn GW; de Rooy RE
    Neurology; 1968 Apr; 18(4):408-12. PubMed ID: 4232362
    [No Abstract]   [Full Text] [Related]  

  • 13. Degradation of connectin (titin) in Fukuyama type congenital muscular dystrophy: immunochemical study with monoclonal antibodies.
    Matsumura K; Shimizu T; Sunada Y; Mannen T; Nonaka I; Kimura S; Maruyama K
    J Neurol Sci; 1990 Sep; 98(2-3):155-62. PubMed ID: 2243226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial MRI in Fukuyama type congenital muscular dystrophy.
    Aihara M; Tanabe Y; Kato K
    Neuroradiology; 1992; 34(5):396-8. PubMed ID: 1407518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of human brain development: glycoconjugate and lipid changes in congenital athyroidism.
    Annunziata P; Federico A; D'Amore I; Corona RM; Guazzi GC
    Early Hum Dev; 1983 Oct; 8(3-4):269-78. PubMed ID: 6227470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac involvement in Fukuyama muscular dystrophy is less severe than in Duchenne muscular dystrophy.
    Yamamoto T; Taniguchi-Ikeda M; Awano H; Matsumoto M; Lee T; Harada R; Imanishi T; Hayashi N; Sakai Y; Morioka I; Takeshima Y; Iijima K; Saegusa J; Toda T
    Brain Dev; 2017 Nov; 39(10):861-868. PubMed ID: 28578814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
    Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
    Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Dutch siblings with congenital muscular dystrophy (Fukuyama type).
    Vles JS; de Krom MC; Visser R; Höweler CJ
    Clin Neurol Neurosurg; 1983; 85(3):175-80. PubMed ID: 6315292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid composition of human neural tumors.
    Yates AJ; Thompson DK; Boesel CP; Albrightson C; Hart RW
    J Lipid Res; 1979 May; 20(4):428-36. PubMed ID: 458265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital muscular dystrophy with complete laminin-alpha2-deficiency, cortical dysplasia, and cerebral white-matter changes in children.
    Tsao CY; Mendell JR; Rusin J; Luquette M
    J Child Neurol; 1998 Jun; 13(6):253-6. PubMed ID: 9660506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.